AKT1 and neoplasm: Many groups have reported that aberrant activation of AKT and ERK1/2 signaling pathways is important for the development of the MDR phenotype of tumor cells, and the suppression of ERK/AKT signaling is considered an effective therapeutic approach to overcome MDR [37, 38].